Agility Robotics Announces Audit Committee Chair for Planned Public-Company Board Life Science Investing
Summit Therapeutics Announces Opening of Global Phase II Study of Ivonescimab-Based Regimens in Advanced Clear Cell Renal Cell Carcinoma Life Science Investing
Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology Congress 2026 Life Science Investing
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026 Life Science Investing
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer's Disease Life Science Investing
Exelixis to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026 Life Science Investing
Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference Life Science Investing
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference Life Science Investing
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
